ARS Pharmaceuticals logo
ARS Pharmaceuticals
SPRY | NASDAQ
Chart Builder DCF Calculator
$3.59
-$0.30 (-7.71%)
At close: Nov 16, 2026, 4:00 PM ET
$3.59
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

ARS Pharmaceuticals Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-35.59M -62.34M -60.62M -41.32M -51.15M -44.88M -33.94M 49.93M -19.13M -12.52M -10.29M -7.17M -14.87M -17.37M -14.96M -14.43M -6.58M -6.42M -7.25M -23.46M -22.66M -24.5M -18.87M
415K 416K 397K 417K 2.35M 279K 280K 158K 21K 18K 11K 12K 21K 20K 20K 14K 7K 488K 50K 430K 541K 492K 466K
8.12M 12.4M 7.42M 5.74M 5.69M 5.37M 5.3M 4.26M 3.59M 3.37M 3.32M 2.28M 2.61M – – 4.76M 460K – 264K – – – –
– -2.74M -585K 141K 1.01M 4.17M -5.01M -9.54M -508K 692K 892K -1.89M -91K 111K -2.69M -1.11M 52K -689K 12K -3.04M -1.66M 557K -294K
-6.66M 1.44M -745K -852K -2.87M 693K -1.96M -1.67M 2.51M -1.9M -1.98M 9.43M -1.56M 346K 441K -10.06M 710K -86K -1K 5.15M 5.02M 4.73M 4.29M
– – – – – – – – – – – -11.18M – – – – – – – – – – –
– -12.84M 8.6M -7.46M -1.07M -1.05M -10.42M -10.68M -1.46M 3.76M 2.24M -10.77M 1.03M 335K 2.07M -781K -276K -956K 12K -3.43M -2.02M 5.14M 1.91M
-33.71M -60.93M -44.95M -43.49M -47.05M -39.59M -40.74M 42M -14.47M -7.28M -6.71M -17.41M -12.76M -16.67M -12.43M -20.5M -5.68M -6.97M -6.93M -21.31M -19.12M -14.14M -12.2M
– – – – -197K -51K -91K -302K -140K -38K -83K 91K -43K -30K -193K -126K -30K -22K -21K -550K -87K -700K -35K
– – – – – – – – – – – -25.95M 46.6M – – – – – – – – – –
-33.06M -19.91M -14.71M -48.89M -127.42M -31.38M -34.35M -163.46M -41.54M -87.61M -63.43M -34.05M -106.6M – -131.35M – – – – -25.14M -39.97M – –
56.47M 61.48M 42.5M 75M 88.5M 80M 63.5M 67M 61M 75M 55M 60M 60M 45M 20M – – – – – – – –
– – – -2M -5.86M – – -5M -2.5M – – 25.95M -46.6M – – – – – – – – – –
23.41M 41.57M 27.79M 24.11M -44.98M 48.57M 29.06M -101.76M 16.82M -12.65M -8.51M 26.04M -46.64M 44.97M -111.55M -126K -30K -22K -21K -25.69M -40.06M -700K -35K
– – – -732K 96.99M – – – – – – – – – – -5.95M -909K -910K -908K – – -496K -350K
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
27.76M 2.41M 97K 83K 2.58M – – 69.38M – – – – – – – 199.77M -647K – – – – – –
27.76M 3.2M 159K 1.13M 100.05M 2.7M 725K 70.92M 680K 545K 258K 1.81M 921K 2.85M 1.32M 193.82M -1.56M -623K -908K 275K 148K 319K -128K
17.46M -16.16M -17M -18.24M 8.02M 11.68M -10.95M 11.16M 3.03M -19.38M -14.97M 10.44M -58.49M 31.16M -122.66M 173.2M -7.27M -15.3M -7.85M -46.62M -59.03M -14.52M -12.36M
-33.71M -60.93M -44.95M -43.49M -47.24M -39.64M -40.83M 41.7M -14.61M -7.32M -6.79M -17.31M -12.81M -16.7M -12.62M -20.62M -5.71M -7M -6.95M -21.86M -19.21M -14.84M -12.24M
-41.84M -73.32M -52.37M -49.22M -52.93M -45.01M -46.13M 37.44M -18.2M -10.68M -10.11M -19.59M -15.42M -16.7M -12.62M -25.39M -6.17M -7M -7.21M -21.86M -19.21M -14.84M -12.24M
– – – – – – – – – – -83K 91K -43K -30K -193K -126K -30K -22K -21K -184.84K -87K – –
– – – – -197K -51K -91K -302K -140K -38K – – – – – – – – – -365.16K – -700K -35K
-33.71M -60.93M -44.95M -43.49M -47.05M -39.59M -40.74M 42M -14.47M -7.28M -6.79M -17.31M -12.81M -16.7M -12.62M -20.62M -5.71M -7M -6.95M -21.49M -19.21M -14.14M -12.2M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.